2018
DOI: 10.1016/j.expneurol.2018.06.009
|View full text |Cite
|
Sign up to set email alerts
|

Antagonizing bone morphogenetic protein 4 attenuates disease progression in a rat model of amyotrophic lateral sclerosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
18
0

Year Published

2019
2019
2022
2022

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 12 publications
(20 citation statements)
references
References 46 publications
2
18
0
Order By: Relevance
“…Considering that only 12 TFs (out of 1211 human TFs) belong to the gliosis-associated gene module identified in MS SCs, the presence of SMAD1 and SOX2 in the short list of currently known HOXA5 TF partners corresponds to an enrichment factor of 31.74 with an associated p-value of 0.002 (Fisher’s exact test). Of note, several works demonstrated the progliotic effects of SOX2 and SMAD1 [39,40,41]. Furthermore, SMAD1 belongs to the BMP (bone morphogenetic protein) and to the TGFB1 signaling pathways [42,43,44,45], both of which have been involved in astrocytosis [46,47].…”
Section: Resultsmentioning
confidence: 99%
“…Considering that only 12 TFs (out of 1211 human TFs) belong to the gliosis-associated gene module identified in MS SCs, the presence of SMAD1 and SOX2 in the short list of currently known HOXA5 TF partners corresponds to an enrichment factor of 31.74 with an associated p-value of 0.002 (Fisher’s exact test). Of note, several works demonstrated the progliotic effects of SOX2 and SMAD1 [39,40,41]. Furthermore, SMAD1 belongs to the BMP (bone morphogenetic protein) and to the TGFB1 signaling pathways [42,43,44,45], both of which have been involved in astrocytosis [46,47].…”
Section: Resultsmentioning
confidence: 99%
“…In humans, elevated BMP signals disrupted the normal development of the palate and teeth [31,32]. Other studies demonstrated that BMP4 is related to the malformation of tissues and organs, such as dysplasia of the lumbosacral spinal cord in rats [33], in multiplex nonsyndromic cleft lip with or without cleft palate in humans [34,35], and in enhancing astrocytosis, microgliosis, and amyotrophic lateral sclerosis [36]. Furthermore, the ectopic osteogenesis of fibrodysplasia ossificans progressiva is associated with overexpression of BMP4 in lymphocytes, which suggests that an inappropriate enhancement of BMP4 expression may play an essential role in the molecular pathophysiology of fibrodysplasia ossificans progressiva [37,38].…”
Section: Discussionmentioning
confidence: 99%
“…Indomethacin, a non-steroidal anti-inflammatory drug, significantly reduced microglial activation in a rat model of focal ischemia model (Lopes et al, 2016 ). Noggin is an endogenous antagonist of bone morphogenetic proteins (BMPs) such as BMP 2 and BMP 4 (Shijo et al, 2018 ; Chien et al, 2020 ). In a rat model of amyotrophic lateral sclerosis, antagonizing BMP4 attenuated disease progression through suppressing microglia and astrocyte activation, and noggin supplementation significantly ameliorated the progression of the disease, suggesting that noggin might modulate glia function through regulating BMPs (Shijo et al, 2018 ).…”
Section: Microglia As Therapeutic Targets For Ischemic Brain Injuriesmentioning
confidence: 99%
“…Noggin is an endogenous antagonist of bone morphogenetic proteins (BMPs) such as BMP 2 and BMP 4 (Shijo et al, 2018 ; Chien et al, 2020 ). In a rat model of amyotrophic lateral sclerosis, antagonizing BMP4 attenuated disease progression through suppressing microglia and astrocyte activation, and noggin supplementation significantly ameliorated the progression of the disease, suggesting that noggin might modulate glia function through regulating BMPs (Shijo et al, 2018 ). In the MCAO mice model, noggin was found to be involved in the regulation of microglia polarization.…”
Section: Microglia As Therapeutic Targets For Ischemic Brain Injuriesmentioning
confidence: 99%